Answers are grounded in this paper and cite their sources.
Isolation of syzydyerin A showed significant acetylcholinesterase inhibition with IC50 of 50.4 µm, suggesting potential as a bioactive compound.
A new unusual C-methylated chalcone was successfully isolated from the leaves of Syzygium dyerianum (King) Chantaran. & J.Parn, identified as syzydyerin A ( 1 ), together with β -sitosterol, friedelin and lupeol. The characterisation and structural elucidation of the isolated compounds were established by extensive spectroscopic data analysis and comparison with literature data. Compound 1 exhibited inhibitory activity against acetylcholinesterase (AChE) and lipoxygenase (LOX) with IC50 values of 50.4 ± 0.2 µm and 30.7 ± 0.25 µm, respectively, compared to the reference inhibitors galantamine (IC50 = 40.7 ± 0.12 µm) for AChE and quercetin (IC50 = 3.5 ± 0.13 µm) 5-LOX. Molecular docking analysis revealed that compound 1 exhibits strong binding affinities toward AChE (−11.0 kcal/mol) and 5-LOX (−9.1 kcal/mol), comparable to standard inhibitors, with key π – π stacking and hydrogen bonding interactions stabilizing its binding at both active sites, highlighting its promising dual inhibitory potential. The study underscores the value of S. dyerianum as a source of bioactive compounds with potential applications in treating neuroinflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Rahim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: